Skip to main content
Top
Published in: Virchows Archiv 5/2018

01-11-2018 | Brief Report

Head and neck manifestations of an undiagnosed McCune-Albright syndrome: clinicopathological description and literature review

Authors: Beatriz Lecumberri, José Juan Pozo-Kreilinger, Isabel Esteban, Mariana Gomes, Aránzazu Royo, Álvaro Gómez de la Riva, Guiomar Pérez de Nanclares

Published in: Virchows Archiv | Issue 5/2018

Login to get access

Abstract

Craniofacial fibrous dysplasia, characteristic of McCune-Albright syndrome (MAS), is usually present in patients with MAS-related acromegaly. We report here the first case of a patient with an undiagnosed MAS presenting with an acute hydrocephalus. A 21-year-old male with gigantism and craniofacial fibrous dysplasia consulted for rapidly progressive headache. An acute obstructive hydrocephalus due to a 39 × 35-mm cystic lesion in the third ventricle was discovered and operated, obtaining hydrocephalus resolution. Pathology described a colloid cyst material and a growth hormone-secreting pituitary adenoma. Genetic study revealed the mosaic GNAS R201H mutation in the pituitary tissue, confirming a MAS diagnosis. Adequate hormonal control was achieved postoperatively. Our results suggest that long-term untreated growth hormone excess in patients with MAS-related craniofacial fibrous dysplasia might end compromising cerebrospinal fluid flow. A prompt diagnosis and coordinated multidisciplinary treatment may help to avoid long-term deleterious impact of hyperfunctioning endocrinopathies in these patients.
Literature
1.
go back to reference Vasilev V, Daly AF, Thiry A, Petrossians P, Fina F, Rostomyan L, Silvy M, Enjalbert A, Barlier A, Beckers A (2014) McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient. J Clin Endocrinol Metab 99:E2029–E2038CrossRef Vasilev V, Daly AF, Thiry A, Petrossians P, Fina F, Rostomyan L, Silvy M, Enjalbert A, Barlier A, Beckers A (2014) McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient. J Clin Endocrinol Metab 99:E2029–E2038CrossRef
2.
go back to reference Salenave S, Boyce AM, Collins MT, Chanson P (2012) Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 99:1955–1969CrossRef Salenave S, Boyce AM, Collins MT, Chanson P (2012) Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 99:1955–1969CrossRef
3.
go back to reference Yao Y, Liu Y, Wang L, Deng K, Yang H, Lu L, Feng F, Xing B, You H, Jin Z, Wang R, Pan H, Chen S, Zhu H (2017) Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome. Eur J Endocrinol 176:295–303 176:295–303CrossRef Yao Y, Liu Y, Wang L, Deng K, Yang H, Lu L, Feng F, Xing B, You H, Jin Z, Wang R, Pan H, Chen S, Zhu H (2017) Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome. Eur J Endocrinol 176:295–303 176:295–303CrossRef
4.
go back to reference Vortmeyer AO, Gläsker S, Mehta GU, Abu-Asab MS, Smith JH, Zhuang Z, Collins MT, Oldfield EH (2012) Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome. J Clin Endocrinol Metab 97:2404–2413CrossRef Vortmeyer AO, Gläsker S, Mehta GU, Abu-Asab MS, Smith JH, Zhuang Z, Collins MT, Oldfield EH (2012) Somatic GNAS mutation causes widespread and diffuse pituitary disease in acromegalic patients with McCune-Albright syndrome. J Clin Endocrinol Metab 97:2404–2413CrossRef
5.
go back to reference Galland F, Kamenicky P, Affres H, Reznik Y, Pontvert D, le Bouc Y, Young J, Chanson P (2006) McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab 91:4957–4961CrossRef Galland F, Kamenicky P, Affres H, Reznik Y, Pontvert D, le Bouc Y, Young J, Chanson P (2006) McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients. J Clin Endocrinol Metab 91:4957–4961CrossRef
6.
go back to reference Nerlich A, Peschel O, Löhrs U, Parsche F, Betz P (1991) Juvenile gigantism plus polyostotic fibrous dysplasia in the Tegernsee giant. Lancet 338:886–887CrossRef Nerlich A, Peschel O, Löhrs U, Parsche F, Betz P (1991) Juvenile gigantism plus polyostotic fibrous dysplasia in the Tegernsee giant. Lancet 338:886–887CrossRef
7.
go back to reference Boyce AM, Burke A, Cutler Peck C, DuFresne CR, Lee JS, Collins MT (2016) Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg 137:1833–1839CrossRef Boyce AM, Burke A, Cutler Peck C, DuFresne CR, Lee JS, Collins MT (2016) Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg 137:1833–1839CrossRef
8.
go back to reference Pamir MN, Peker S, Ozgen S et al (2004) Anterior transcallosal approach to the colloid cysts of the third ventricle: case series and review of the literature. Zentralbl Neurochir 65:108–115CrossRef Pamir MN, Peker S, Ozgen S et al (2004) Anterior transcallosal approach to the colloid cysts of the third ventricle: case series and review of the literature. Zentralbl Neurochir 65:108–115CrossRef
9.
go back to reference Shin SJ, Lee SJ, Kim SK (2017) Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: pyrosequencing analysis in tissue samples with or without decalcification. Sci Rep 7:2836CrossRef Shin SJ, Lee SJ, Kim SK (2017) Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: pyrosequencing analysis in tissue samples with or without decalcification. Sci Rep 7:2836CrossRef
10.
go back to reference O'Hayre M, Vázquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS (2013) The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13:412–424CrossRef O'Hayre M, Vázquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS (2013) The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13:412–424CrossRef
11.
go back to reference Okamoto S, Hisaoka M, Ushijima M, Nakahara Nakahara S, Toyoshima S, Hashimoto H (2000) Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch 437:133–137 Okamoto S, Hisaoka M, Ushijima M, Nakahara Nakahara S, Toyoshima S, Hashimoto H (2000) Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch 437:133–137
12.
go back to reference Wood LD, Noë M, Hackeng W, Brosens LAA, Bhaijee F, Debeljak M, Yu J, Suenaga M, Singhi AD, Zaheer A, Boyce A, Robinson C, Eshleman JR, Goggins MG, Hruban RH, Collins MT, Lennon AM, Montgomery EA (2017) Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch 470:391–400CrossRef Wood LD, Noë M, Hackeng W, Brosens LAA, Bhaijee F, Debeljak M, Yu J, Suenaga M, Singhi AD, Zaheer A, Boyce A, Robinson C, Eshleman JR, Goggins MG, Hruban RH, Collins MT, Lennon AM, Montgomery EA (2017) Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch 470:391–400CrossRef
Metadata
Title
Head and neck manifestations of an undiagnosed McCune-Albright syndrome: clinicopathological description and literature review
Authors
Beatriz Lecumberri
José Juan Pozo-Kreilinger
Isabel Esteban
Mariana Gomes
Aránzazu Royo
Álvaro Gómez de la Riva
Guiomar Pérez de Nanclares
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 5/2018
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-018-2396-z

Other articles of this Issue 5/2018

Virchows Archiv 5/2018 Go to the issue